Active Failures Seen in Proper Use of Personal Protective Equipment

Share this content:
Active Failures Seen in Proper Use of Personal Protective Equipment
Active Failures Seen in Proper Use of Personal Protective Equipment

TUESDAY, June 12, 2018 (HealthDay News) -- Active failures frequently occur in infectious agent transmission-based precautions, including personal protective equipment (PPE) use, according to a study published online June 11 in JAMA Internal Medicine.

Sarah L. Krein, Ph.D., R.N., from the VA Ann Arbor Healthcare System in Michigan, and colleagues conducted a qualitative study involving direct observation inside and outside patient rooms in medical and/or surgical units and intensive care units at an academic medical center and Veterans Affairs hospital, as well as the emergency department of a university hospital. Through a directed content analysis, specific occurrences involving potential personnel self-contamination were identified by trained observers.

A total of 325 room observations were conducted at two sites; 79.7 percent occurred outside and 20.3 percent inside the room. The researchers observed 283 failures, including 102 violations, 144 process or procedural mistakes, and 37 slips. Violations included entering rooms without some or all recommended PPE; during PPE removal, mistakes were frequently observed, as well as during encounters with challenging logistical situations, such as badge-enforced computer logins. Touching one's face or clean areas with contaminated gloves or gowns were included as slips. The likelihood of resulting in self-contamination was considerable for each of these active failures.

"The factors that contributed to these failures varied widely, suggesting the need for a range of strategies to reduce potential transmission risk during routine hospital care," the authors write.

Abstract/Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »